Tag: CSIR

The kit consists of a nasopharyngeal/oropharyngeal swab which, post sampling, is placed in a stabilizing solution containing RNAShield™, a proprietary US FDA approved reagent from US based Zymo Research................

The program has extended support to 225 aspirants and has been immensely successful in boosting the spirit of entrepreneurship among the youth in India...................

Remarked Minister of Science and Technology, Dr Harsh Vardhan while releasing a compendium of more than 100 technologies, 93 industry partners listed and with over 60 of these technologies having been transferred to the industry by CSIR....................

CSIR-CMERI, Durgapur, unveiled the  COVID Protection System (COPS) for Workplace as a game-changer in the current Pandemic Scenario............

This drug has a good safety profile and acts by preventing the entry of virus into human cells and also by priming the immune system......................

Through this competition ‘Know your Medicinal and Aromatic Plants (MAPs)’, Central Institute of Medicinal and Aromatic Plants (CIMAP) wants to convey the message of conservation of these medicinal plants......................

As more than 20 percent of people with type-1 diabetes below the age of 15 years of age are in India, developing a genetic test kit to reliably detect type-1 from type-2 diabetes holds a lot of significance for the country.....................

The lectures delivered during webinar series on “Bio-methodology of Laboratory Animals” were specially intended for students and project staff who are working on animals...................

The Indian Council of Medical Research (ICMR) has recommended only a reverse transcription-polymerase chain reaction (RT-qPCR) test for novel coronavirus testing. Researchers at the Centre for Cellular and Molecular Biology (CCMB) have developed a new low-cost and low-tech required test for SARS-CoV-2 testing..................

Approval from the New Drugs Division of Central Drugs Standard Control Organization (CDSCO) will pave way for CSIR-Indian Institute of Integrative Medicine (IIIM) Jammu for conducting the clinical trial of this important drug candidate IIIM-290 in pancreatic cancer patients....................